STANDARD BIOTOOLS INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Standard Biotools Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Standard Biotools Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $124M, a 15% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $124M +$16.2M +15% Dec 31, 2023 10-K 2024-03-01
Q4 2022 $108M -$33.2M -23.5% Dec 31, 2022 10-K 2024-03-01
Q4 2021 $141M +$9.86M +7.51% Dec 31, 2021 10-K 2023-03-14
Q4 2020 $131M +$1.15M +0.88% Dec 31, 2020 10-K 2022-03-08
Q4 2019 $130M +$3.98M +3.15% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $126M +$6.88M +5.77% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $119M -$27.1M -18.5% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $146M +$22.1M +17.8% Dec 31, 2016 10-K 2018-03-08
Q4 2015 $124M +$14M +12.7% Dec 31, 2015 10-K 2017-03-03
Q4 2014 $110M +$13.9M +14.4% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $96.3M +$5.66M +6.25% Dec 31, 2013 10-K 2015-02-26
Q4 2012 $90.6M +$5.29M +6.2% Dec 31, 2012 10-K 2014-03-12
Q4 2011 $85.3M Dec 31, 2011 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.